By combining Kushenol A and PI3K inhibitor, it was confirmed that proliferative capacity of BC cells was further reduced, indicating that Kushenol A inhibited BC cell proliferation and facilitated apoptosis via the PI3K/AKT/mTOR pathway. The gene discussed is AKT1; the disease is breast cancer.